-
Prostate Cancer Screening
Part 2: Is It Right for You? In Part 1, we covered the basics: the prostate is a small gland that can develop cancer as men age. Prostate cancer is common but very treatable when caught early. Screening – primarily through a PSA blood test and a brief physical exam – looks for early warning…
Categories:
By
-
The Importance of Prostate Cancer Screening for Men
The blog discusses the importance of prostate cancer screening, illustrated by Dave’s story, who was diagnosed early after a routine checkup. It explains what prostate cancer is, why early detection matters, and outlines screening methods like the PSA blood test and Digital Rectal Exam (DRE). Part 2 will address who should get screened.
Categories:
By
-
Breakthrough Antisense Oligonucleotide Treatments Explained
Claire’s story highlights her transformation from a child with spinal muscular atrophy to one able to walk and communicate, thanks to the breakthrough antisense oligonucleotide therapy, Spinraza. This therapy symbolizes hope for many genetic conditions, though challenges remain, including delivery difficulties, side effects, high costs, and the need for further research in efficacy and access.
Categories:
By
-
Understanding AAV Therapies: A Breakthrough for Genetic Diseases
Baby Josephine and her sister Evelyn both faced spinal muscular atrophy type 1. Traditional treatments failed, but Evelyn’s participation in a clinical trial for the gene therapy Zolgensma transformed her life. Despite its $2.1 million cost and risks, early intervention with Zolgensma significantly improved outcomes for children diagnosed with SMA.
By
-
Revolutionizing Sickle Cell Treatment with CRISPR
Victoria Gray, diagnosed with sickle cell disease (SCD) at three months, defied a seven-year life expectancy, suffering for 34 years. Traditional treatments failed until she participated in a groundbreaking CRISPR trial, successfully reactivating healthy hemoglobin production. Victoria is now pain-free, showcasing the potential of genetic medicine to cure chronic conditions.
Categories:
By
-
Beyond Pills and Surgery: The Therapeutic Revolution Happening Now
For over a century, traditional medicine offered pills and surgery, effectively managing many conditions. However, it often falls short for genetic diseases. The advent of precision therapies, such as CRISPR and AAV gene therapy, marks a revolutionary shift, curing root causes rather than managing symptoms, thus transforming patient outcomes.
Categories:
By
-
Human body and microbiome
The gut microbiome significantly influences health, particularly concerning colon cancer. Research reveals links between specific microbes and the disease, especially in high-risk individuals. Understanding gut microbiota dysbiosis and its mechanisms can guide dietary choices to prevent colon cancer. While microbiome testing is evolving, widespread accessibility remains a challenge.
Categories:
By
-
Improving Accuracy in Whole Genome Sequencing
Next-generation sequencing (NGS) is essential for clinical diagnostics, but limitations in variant detection arise from challenging genomic regions and low-frequency variants. Improvements in long-read sequencing and bioinformatics may enhance test accuracy. Additionally, standardization of workflows and the use of commutable reference materials are critical for reliable genetic testing across laboratories.
Categories:
By
-
The Rise and Fall of 23andMe: A Cautionary Tale
23andMe, the pioneer in direct-to-consumer genetic testing, faced a downfall after a data breach in 2023, leading to bankruptcy and the resignation of its founder. Despite previous partnerships and efforts to monetize customer data, the lack of transparency raised significant privacy concerns. Its assets were acquired by the TTAM Research Institute, bringing hope for the…
By
-
The Future of Newborn Screening: Genomics and Challenges
Newborn screening (NBS) is crucial for early detection of severe health conditions in infants, enabling timely interventions that can prevent disabilities or death. While the testing varies globally, the push for genomic screening is increasing. Challenges include ethical considerations, disparities in access, and the need for consistent screening panels across different programs.
Categories:
By
Making sense of your genome